Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioView, Transgenomic combine for in-vitro distribution pact:

This article was originally published in Clinica

Executive Summary

Rehovot, Israel-based cell imaging specialist BioView is expanding its European sales penetration by combining with biotechnology company Transgenomic to distribute its scanning and analysis workstations in western Europe and Scandinavia. BioView's products, including its Duet, Allegro and Accord automated workstations, will be marketed, sold and serviced through Transgenomic's European sales force. BioView had previously sold its Duet system to university hospitals and commercial laboratories in the US and Europe through its own sales force. The company's automated scanning microscopes and image analysis systems are designed for in-vitro diagnostic use - particularly to aid the detection, classification and counting of cells for haematological, breast cancer, bladder cancer, and prenatal and postnatal genetic testing. Transgenomic (Omaha, Nebraska) said that the deal proved to be complementary to its existing line of cytogenetics products for genetic variation and mutation analysis. Financial terms of the deal were not disclosed.

You may also be interested in...

QUOTED. 6 April 2020. Bethany Hills.

Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.

Health And Wellness Trademark Review 31 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery

Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts